Lyra Therapeutics, Inc. - LYRA
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| May 15, 2026 | — | D | D | 640.0 | 0.0 | 0.0 | 0.0 | View | |
| Apr 03, 2026 | Principal Financial Officer | D | D | 667.0 | 0.0 | 0.0 | 517,880.0 | View | |
| Apr 03, 2026 | Principal Executive Officer | D | D | 2,000.0 | 0.0 | 0.0 | 1,094,733.0 | View | |
| Jan 08, 2026 | President & CEO | S | D | 1,702.0 | 3.364 | 5,725.53 | 1,096,733.0 | View | |
| Jan 08, 2026 | Chief Financial Officer | S | D | 769.0 | 3.364 | 2,586.92 | 518,547.0 | View |